David Maussang
Impact in
- Immunology top 5%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- Oncology top 5%
- Chemokine receptors and signaling
Papers in
- Oncology 17
- Chemokine receptors and signaling 8
- Viral-associated cancers and disorders 4
- HER2/EGFR in Cancer Research 4
- Co-authors
- Martine J. Smit (15 shared papers)Rob Leurs (9 shared papers)Sérgio A. Lira (3 shared papers)Guus A.M.S. van Dongen (2 shared papers)Pieter J. Gaillard (3 shared papers)Erik Slinger (4 shared papers)Andreas Schreiber (3 shared papers)Detlef Michel (3 shared papers)
- Journals
- Drug Discovery Today Technologies (2 papers)Journal of Biological Chemistry (2 papers)Proceedings of the National Academy of Sciences (2 papers)PLoS ONE (2 papers)Cancer Cell (2 papers)
- Partner nations
- NetherlandsUnited StatesBelgium
In The Last Decade
David Maussang
23 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 89
- Immunology 670
- Oncology 691
- Radiology, Nuclear Medicine and Imaging 430
- Biomaterials 219
- Epidemiology 553
Countries citing papers authored by David Maussang
This map shows the geographic impact of David Maussang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Maussang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Maussang more than expected).
Fields of papers citing papers by David Maussang
This network shows the impact of papers produced by David Maussang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Maussang. The network helps show where David Maussang may publish in the future.
Co-authors
The 25 scholars most cited alongside David Maussang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 208 | |
| 2 | 2011 | 200 | |
| 3 | 2010 | 198 | |
| 4 | 2010 | 178 | |
| 5 | 2006 | 177 | |
| 6 | 2008 | 154 | |
| 7 | 2009 | 128 | |
| 8 | 2013 | 124 | |
| 9 | 2014 | 119 | |
| 10 | 2010 | 89 | |
| 11 | 2018 | 84 | |
| 12 | 2016 | 65 | |
| 13 | 2012 | 51 | |
| 14 | 2012 | 35 | |
| 15 | 2012 | 34 | |
| 16 | 2018 | 31 | |
| 17 | 2017 | 25 | |
| 18 | 2019 | 24 | |
| 19 | 2019 | 23 | |
| 20 | 2012 | 19 |
About David Maussang
David Maussang is a scholar working on Oncology, Molecular Biology, Epidemiology, Radiology, Nuclear Medicine and Imaging and Immunology, having authored 23 papers that have together received 2.0k indexed citations. Recurring topics across this work include Chemokine receptors and signaling (8 papers), Cytomegalovirus and herpesvirus research (7 papers), Monoclonal and Polyclonal Antibodies Research (7 papers), Viral-associated cancers and disorders (4 papers), HER2/EGFR in Cancer Research (4 papers), T-cell and B-cell Immunology (3 papers), Immunotherapy and Immune Responses (3 papers) and Herpesvirus Infections and Treatments (3 papers). The work is most often cited by research in Immunology (670 citations), Oncology (691 citations), Radiology, Nuclear Medicine and Imaging (430 citations), Biomaterials (219 citations) and Epidemiology (553 citations). David Maussang has collaborated with scholars based in Netherlands, United States and Belgium. Frequent co-authors include Martine J. Smit, Rob Leurs, Sérgio A. Lira, Guus A.M.S. van Dongen, Pieter J. Gaillard, Erik Slinger, Andreas Schreiber, Detlef Michel, Chantal C.M. Appeldoorn and Maikel Wijtmans. Their work appears in journals such as Drug Discovery Today Technologies, Journal of Biological Chemistry, Proceedings of the National Academy of Sciences, PLoS ONE and Cancer Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.